|
The Scotsman
National broadsheet |
|
Relevance: The AngioTracker "anti-cancer" drug evaluation instrument
Date: 16 June 2001 By: Alastair Jamieson and Michelle Nichols
Headline: Cancer 'cure' is found
"Early tests of a revolutionary drug and radiation cancer treatment invented by British scientists have proved dramatically successful, it was revealed yesterday. Laboratory mice...were completely cured in 85 per cent of cases. ..."
HIC comments: Although the success rates achieved by this London-based team are very promising, one of the best routes to improving these figures and hence saving even more lives is by studying the effectiveness of different combinations of drugs using an instrument such as the AngioTracker.
|
Press & Journal
Regional broadsheet |
|
Relevance: The PhonoJect reusable needle-free injection device
Date: 7 April 2001 By: Not Stated
Headline: £270,000 to combat needlestick injuries
"New guidelines to help reduce the incidence of needlestick injuries to NHS staff have been issued by the Scottish Executive along with financial aid to tackle the problem, it was announced yesterday. About 10 million..."
HIC comments: The cost of needle-stick injuries to both healthcare-professionals and patients, including those associated with staff absenteeism and malpractice lawsuits, are growing at such a rate that needle-free injection devices, such as the PhonoJect, are becoming an increasingly attractive alternative.
|
The Times
National broadsheet |
|
Relevance: The AngioTracker "anti-cancer" drug evaluation instrument
Date: 26 March 2001 By: Joanna Bale
Headline: Ultrasound to monitor cancer treatment
"Ultrasound can provide a simple and painless way to monitor how cancer patients respond to chemotherapy, British researchers said yesterday. The finding, by researchers at Charing Cross and Hammersmith Hospitals..."
HIC comments: This report confirms our view that Ultrasound-based instruments represent a breakthrough in the fight against cancer, in particular, enabling scientists to determine which drugs are most effective at removing tumours.
|
The Sunday Times
National broadsheet |
|
Relevance: The BreastChecker consumer breast inspection device
Date: 18 February 2001 By: Lois Rogers (Medical Correspondent)
Headline: Breast scan blunder forces cancer review
"Breast scans from 103,000 women taken at a leading cancer centre are to be re-examined in one of the biggest reviews undertaken since the national breast screening programme was launched in 1988. Fears that cancerous tumours..."
HIC comments: The UK National Breast Screening Programme use X-Ray Mammography as their principal method of checking for suspicious lumps. Although there are many factors which can effect the percentage of missed cancers, not least the experience of the Radiologist, estimates are as high as 15%. HIC has developed a device called the BreastChecker which could be used to complement the latter technique and hence reduce the number of missed tumours still further.
|
The Independent
National broadsheet |
|
Relevance: The BreastChecker consumer breast inspection device
Date: 7 October 2000 By: Cherry Norton (Social Affairs Editor)
Headline: £345,000 for woman given false diagnosis
"A nurse aged 63 who suffered years of major operations, including losing both breasts, after she was misdiagnosed as having cancer won £345,222 in damages yesterday. Jennifer Cormack, who had a history of benign breast lumps..."
HIC comments: Cancer misdiagnosis errors can result in legal bills that are more than a thousand times the cost of a single BreastChecker. Even if this device could only catch 10 per cent of lumps missed by X-Ray Mammography it would pay for itself many times over.
|
The Times
National broadsheet |
|
Relevance: The PhonoJect reusable needle-free injection device
Date: 11 July 2000 By: Anthea Lawson
Headline: Medisys will use specialist to market Futura
"Medisys, whose Futura Safety syringe gained US regulatory approval last week, said yesterday the product would be marketed by an executive from Becton Dickinson, which has 70 per cent of the..."
HIC comments: It is currently illegal to use non-safety syringes in nearly a third of all U.S. states.
|
The Sunday Times
National broadsheet |
|
Relevance: The PhonoJect reusable needle-free injection device
Date: 9 July 2000 By: Not Stated
Headline: Experts reveal companies most likely to succeed
"Investors who want to buy shares in smaller companies have hundreds of options. However, these are 10 companies that top fund managers believe hold exciting prospects for the future. [1] Medisys is developing retractable medical needles..."
HIC comments: This article confirms our view that there is growing interest in devices that can reduce of even eliminate needle-stick injuries.
|
Press & Journal
Regional broadsheet |
|
Relevance: The PhonoJect reusable needle-free injection device
Date: 6 July 2000 By: Not Stated
Headline: Injectionless drugs market set to boom
"The market for injectionless treatments for conditions such as diabetes will be worth £10 billion within 10 years, biotechnology group Bespak predicted yesterday. Bespak, aiming to be a leading supplier..."
HIC comments: As needle-free injection technology also has applications in areas such as veterinary medicine, the total market value for devices such as the PhonoJect could be significantly larger than the above figure. |
